The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Vidalta 15 mg prolonged-release tablets for cats

15 mg/tablet Tablet

Intervet Ireland LimitedVPA10996/263/002

Main Information

Trade NameVidalta 15 mg prolonged-release tablets for cats
Active SubstancesCarbimazole
Strength15 mg/tablet
Dosage FormTablet
Licence HolderIntervet Ireland Limited
Licence NumberVPA10996/263/002

Group Information

ATC CodeQH03BB01 carbimazole
Therapeutic ClassHormone
SpeciesCats

Status

Authorised/WithdrawnAuthorised
Licence Issued09/12/2011
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
« Back